Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials

Two large cardiovascular outcome trials of canagliflozin, comprising the CANVAS Program, will complete in early 2017: the CANagliflozin cardioVascular Assessment Study (CANVAS) and the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R). Accruing data for the sodium glucose co‐transporter...

Descripción completa

Detalles Bibliográficos
Autores principales: Neal, Bruce, Perkovic, Vlado, Mahaffey, Kenneth W., Fulcher, Greg, Erondu, Ngozi, Desai, Mehul, Shaw, Wayne, Law, Gordon, Walton, Marc K., Rosenthal, Norm, de Zeeuw, Dick, Matthews, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Clinical Trial Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485085/
https://www.ncbi.nlm.nih.gov/pubmed/28244644
http://dx.doi.org/10.1111/dom.12924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485085/
https://www.ncbi.nlm.nih.gov/pubmed/28244644
http://dx.doi.org/10.1111/dom.12924

Ejemplares similares